Compare FCX & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FCX | COR |
|---|---|---|
| Founded | 1987 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Other Pharmaceuticals |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7B | 68.5B |
| IPO Year | N/A | N/A |
| Metric | FCX | COR |
|---|---|---|
| Price | $62.57 | $360.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | $54.87 | ★ $395.23 |
| AVG Volume (30 Days) | ★ 24.0M | 1.4M |
| Earning Date | 01-22-2026 | 02-04-2026 |
| Dividend Yield | ★ 0.95% | 0.67% |
| EPS Growth | 16.92 | ★ 18.64 |
| EPS | 1.52 | ★ 8.33 |
| Revenue | $25,915,000,000.00 | ★ $325,777,775,000.00 |
| Revenue This Year | $12.14 | $7.19 |
| Revenue Next Year | $15.77 | $6.19 |
| P/E Ratio | ★ $41.34 | $43.31 |
| Revenue Growth | 1.81 | ★ 7.45 |
| 52 Week Low | $27.66 | $237.71 |
| 52 Week High | $69.44 | $377.54 |
| Indicator | FCX | COR |
|---|---|---|
| Relative Strength Index (RSI) | 52.65 | 52.64 |
| Support Level | $58.23 | $347.03 |
| Resistance Level | $65.98 | $374.89 |
| Average True Range (ATR) | 2.79 | 12.26 |
| MACD | -0.47 | 0.04 |
| Stochastic Oscillator | 25.25 | 63.10 |
Freeport-McMoRan owns stakes in 10 copper mines, led by its 49% ownership of the Grasberg copper and gold operations in Indonesia, 55% of the Cerro Verde mine in Peru, and 72% of Morenci in Arizona. It sold around 1.2 million metric tons of copper (its share) in 2024, making it the one of the world's largest copper miners by volume. It also sold about 900,000 ounces of gold, mostly from Grasberg, and 70 million pounds of molybdenum. It had about 25 years of copper reserves at the end of December 2024. We expect it to sell similar amounts of copper midcycle in 2029, though we expect gold volumes to decline to about 650,000 ounces then due to falling production at Grasberg.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.